M6090335
Toremifene , 98% , 89778-26-7
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB820.80 | In Stock |
|
| 500mg | RMB2384.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 108-110°C |
| Boiling point: | 535.1±50.0 °C(Predicted) |
| Density | 1.104±0.06 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | 25℃: DMSO 120mg/mL ;Water <1mg/mL; Ethanol <1mg/mL |
| pka | 8.69±0.28(Predicted) |
| form | Powder |
| color | White to light yellow |
| Stability: | Light sensitive |
| InChI | InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25- |
| InChIKey | XFCLJVABOIYOMF-QPLCGJKRSA-N |
| SMILES | C(/C1C=CC=CC=1)(\C1C=CC(=CC=1)OCCN(C)C)=C(\C1C=CC=CC=1)/CCCl |
| CAS DataBase Reference | 89778-26-7(CAS DataBase Reference) |
| IARC | 3 (Vol. 66) 1996 |
Description and Uses
Toremifene is an antiestrogenic anticancer agent effective in the treatment of advanced recurrent breast cancer in postmenopausal patients. It is claimed to be more effective than tamoxifen in several rat mammary tumor models. Side-effects are mild, including hot flushes and sweating.
An antiestrogen and antineoplastic. Nonsteroidal antiestrogen structurally similar to tamoxifen
Safety
| Symbol(GHS) |    GHS05,GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302-H318-H400-H410 |
| Precautionary statements | P264-P280i-P301+P312a-P305+P351+P338-P310a-P501a |
| HazardClass | 9 |
